The clinical use of milnacipran for depression

European Psychiatry

Volumn 18, Issue 1, 2003, Pages 34-35

  Morishita, Shigeru ^a   Arita, Seizaburo ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antidepressant; Depression; Dose; Milnacipran; Onset of action; Predictor

Indexed keywords

MILNACIPRAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; TREATMENT PLANNING;

EID: 0037299993     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(02)00003-2     Document Type: Article

References (3)

1. Hordern A, Burt CG, Holt NF. Depressive states: a pharmacotherapeutic study. Springfield, IL: Charles C Thomas; 1965 pp. 70-97.
2. Lecrubier Y, Pletan Y, Solles A, Tournoux A, Magne V. Clinical efficacy of milnacipran: placebo-controlled trial. Int Clin Psychopharmacol 1996;11 (Suppl 4):29-33.
3. Spencer CM, Wilde MI. Milnacipran: a review of its use in depression. Drug 1998;56:405-27.